Literature DB >> 30681029

Perspectives on cannabis as a substitute for opioid analgesics.

Sara P Khan1, Thomas A Pickens1, Daniel J Berlau1.   

Abstract

With the opioid epidemic reaching new heights in the USA, it has become critical to find suitable alternatives to opioids. Cannabis, an antinociceptive, is a strong contender to help patients reduce their opioid usage. A growing literature has been examining the complex effects cannabis has on pain relief and on opioid usage; whether it is a substitute for opioids or increases their use. This review explores the studies that compare cannabis-opioid interactions and presents some challenges of cannabis research and usage. The practical clinical pharmacology of cannabis as an analgesic, including the route of administration, safety and pharmacokinetics, are discussed to address the concerns, as well as possible solutions, of cannabis as a pain reliever.

Entities:  

Keywords:  analgesia; marijuana; mu-opioid receptor agonists; opioid-sparing effect; synthetic CB2 agonist

Mesh:

Substances:

Year:  2019        PMID: 30681029     DOI: 10.2217/pmt-2018-0051

Source DB:  PubMed          Journal:  Pain Manag        ISSN: 1758-1869


  10 in total

1.  Perspectives on formation of medical cannabis market in Ukraine based on holistic approach.

Authors:  Nataliia Aliekperova; Кostyantyn Kosyachenko; Oleksandr Kaniura
Journal:  J Cannabis Res       Date:  2020-10-02

Review 2.  Targeting the endocannabinoid system: a predictive, preventive, and personalized medicine-directed approach to the management of brain pathologies.

Authors:  Vamsi Reddy; Dayton Grogan; Meenakshi Ahluwalia; Évila Lopes Salles; Pankaj Ahluwalia; Hesam Khodadadi; Katelyn Alverson; Andy Nguyen; Srikrishnan P Raju; Pankaj Gaur; Molly Braun; Fernando L Vale; Vincenzo Costigliola; Krishnan Dhandapani; Babak Baban; Kumar Vaibhav
Journal:  EPMA J       Date:  2020-04-15       Impact factor: 6.543

3.  Green Hope: Perspectives on Cannabis from People who Use Opioids.

Authors:  Miriam Boeri; Elise Pereira; Alina Minkova; Kevin Marcato; Elianne Martinez; Denise Woodall
Journal:  Sociol Inq       Date:  2020-02-13

4.  The unlikely legalization of medical cannabis in Albania: a case study.

Authors:  Gentian Vyshka
Journal:  J Med Ethics Hist Med       Date:  2018-08-27

Review 5.  Minor Cannabinoids: Biosynthesis, Molecular Pharmacology and Potential Therapeutic Uses.

Authors:  Kenneth B Walsh; Amanda E McKinney; Andrea E Holmes
Journal:  Front Pharmacol       Date:  2021-11-29       Impact factor: 5.810

6.  Jailhouse rock: health status, patterns of use, and subjective benefits of cannabis use in a sample of inmates in Spanish prisons.

Authors:  R Jiménez-Vinaja; M Imbernón; A Parés-Bayerri; G Ona; O Parés; J C Bouso
Journal:  Rev Esp Sanid Penit       Date:  2022 Jan-Apr

7.  Cannabidiol (CBD) and other drug use among young adults who use cannabis in Los Angeles.

Authors:  Ekaterina V Fedorova; Carolyn F Wong; Janna Ataiants; Ellen Iverson; Bridgid M Conn; Stephen E Lankenau
Journal:  Drug Alcohol Depend       Date:  2021-02-22       Impact factor: 4.492

8.  Exploring the use of cannabis as a substitute for prescription drugs in a convenience sample.

Authors:  Sinikka L Kvamme; Michael M Pedersen; Kristine Rømer Thomsen; Birgitte Thylstrup
Journal:  Harm Reduct J       Date:  2021-07-10

9.  Tetrahydrocannabinol Reduces Hapten-Driven Mast Cell Accumulation and Persistent Tactile Sensitivity in Mouse Model of Allergen-Provoked Localized Vulvodynia.

Authors:  Beebie Boo; Rohit Kamath; Erica Arriaga-Gomez; Jasmine Landry; Elizabeth Emanuel; Sookyong Joo; Marietta Saldías Montivero; Tijana Martinov; Brian T Fife; Devavani Chatterjea
Journal:  Int J Mol Sci       Date:  2019-05-01       Impact factor: 5.923

Review 10.  Cannabis and pain: a scoping review.

Authors:  Camila Pantoja-Ruiz; Paula Restrepo-Jimenez; Camilo Castañeda-Cardona; Alexandra Ferreirós; Diego Rosselli
Journal:  Braz J Anesthesiol       Date:  2021-07-16
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.